All Industries

Top Life Sciences Companies

372 Life Sciences companies, sorted by total funding raised.

Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Venture Unknown·$3.2B·May 2026
AsymchemIPO

Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.

Tianjin, China5001–10000Healthcare, Biotech
Private Equity·$2.3B·Feb 2020
Oscar HealthIPO

Health insurance company using technology to make health care simple, affordable, and accessible.

New York, United States1001–5000Healthcare, Insurance
Series F·$1.9B·Jun 2020
Caris Life SciencesIPO

Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...

Irving, United States1001–5000Diagnostics, Genomics
Growth Equity·$1.5B·Apr 2025
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Life Sciences
Series D·$1.4B·Jun 2020
Treeline Biosciences

Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...

Watertown, United States51–200Biotech, Drug Discovery
Extension Round·$1.2B·Sep 2025
ArsenalBio

Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...

San Francisco, United States201–500Biotech, Life Sciences
Series C·$955.0M·Sep 2024
BridgeBioIPO

BridgeBio makes targeted treatments for genetic diseases.

San Francisco Bay Area, United States201–500Biotech, Life Sciences
Convertible·$909.2M·Mar 2020
Pacific Biosciences

Long-read DNA sequencing company providing advanced systems for complete and accurate genome, tra...

Menlo Park, United States501–1000Biotech, Genomics
Convertible·$900.0M·Feb 2021
Cityblock Health

Value-based healthcare provider offering integrated medical, behavioral, and social care for Medi...

Brooklyn, United States501–1000Life Sciences, Healthcare
Series D·$891.3M·Sep 2021
CertaraIPO

Global biosimulation software and services company accelerating drug development for 2,000+ bioph...

Radnor, United States1001–5000Life Sciences, Biosimulation
Private Equity·$850.0M·Jan 2017
Aidoc

Aidoc is a pioneering force in Clinical AI, empowering healthcare teams to optimize patient treat...

Tel Aviv, Israel201–500Life Sciences
Series E·$843.5M·Apr 2026
Parabilis Medicines

Precision medicine company pursuing previously undruggable disease targets using novel therapeuti...

Cambridge, United States201–500Biotech, Life Sciences
Series F·$812.0M·Jan 2026
Commure

Commure (FKA Athelas) is an AI-powered operating system for healthcare providers.

Mountain View, United States501–1000Artificial Intelligence, Healthcare
Growth Equity·$770.0M·Jun 2025
Sword

Sword offers virtual physical therapy services through a combination of AI and human expertise.

New York, United States501–1000Life Sciences
Venture Unknown·$757.6M·Jun 2025
Tessera Therapeutics

Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...

Somerville, United States201–500Biotech, Genomics
Corporate Round·$730.0M·Dec 2025
Lyell ImmunopharmaIPO

Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...

South San Francisco, United States201–500Biotech, Life Sciences
Venture Unknown·$722.0M·Jul 2025
Elemy

Provider of in-home and online pediatric behavioral health and autism care, offering personalized...

San Francisco, United States51–200Digital Health, Healthcare
Series C·$664.0M·May 2023
Element Biosciences

Life science company democratizing access to advanced DNA sequencing tools with high-quality, aff...

San Diego, United States201–500Biotech, Genomics
Series D·$648.3M·Jul 2024
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private Equity·$647.0M·Feb 2026
Synthego

Provides CRISPR reagents, engineered nucleases, and GMP manufacturing to researchers and therapeu...

Redwood City, United States51–200Biotech, Genomics
Series E·$570.0M·Feb 2022
ArvinasIPO

Clinical-stage biotechnology company developing PROTAC protein degraders for oncology and neurode...

New Haven, United States201–500Biotech, Healthcare
Private Equity·$464.9M·Nov 2023
BiofourmisAcquired

AI-driven platform delivering remote patient monitoring and in-home care for health systems, paye...

Boston, United States201–500Artificial Intelligence, Digital Health
Series D·$461.5M·Jul 2022
AlumisIPO

Alumis is a late-stage biopharma company developing targeted therapies for patient with immune-me...

South San Francisco, United States201–500Life Sciences, healthtech
Series C·$459.0M·Mar 2024
Crinetics Pharmaceuticals, Inc.

R&D company with 6 SBIR/STTR awards from Department of Health and Human Services.

San Diego, United States11–50Biotech, Healthcare
Venture Unknown·$453.5M·Jan 2026